PPAR Research / 2013 / Article / Fig 7

Research Article

Interactions between Human Liver Fatty Acid Binding Protein and Peroxisome Proliferator Activated Receptor Selective Drugs

Figure 7

(a) The conformational nuclear localisation signal formed in A-FABP upon binding of an activating ligand. The portal region of A-FABP is shown in ribbon representation in complex with an activator ligand troglitazone (red; PDB code: 2QM9.pdb) and in complex with a non-activator ligand, arachidonic acid (cyan; PDB code: 1ADL.pdb). The side chains of the NLS residues (Lys21, Arg30, Lys31) and cavity lid residue (Phe57) are shown in sticks representation. Below, sequence alignment of the NLS region of human A-FABP, with human I- and L-FABP. NLS residues are highlighted in bold on a grey background. (b) Putative mechanism for the transfer of ligands from FABPs to PPAR LBDs.
938401.fig.007a
(a)
938401.fig.007b
(b)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.